Protara Therapeutics, Inc. (TARA) › Net IncomeProtara Therapeutics, Inc. (TARA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2012: -$7.97M2013: -$7.91M2014: -$3.34M2015: -$21.38M2016: -$28.53M2017: -$29.96M2018: -$20.73M2019: -$7.83M2020: -$33.98M2021: -$47.25M2022: -$65.95M2023: -$40.42M2024: -$44.60M2025: -$57.44M-$57.44M2012Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$57.44M-28.8%2024-$44.60M-10.3%2023-$40.42M+38.7%2022-$65.95M-39.6%2021-$47.25M-39.1%2020-$33.98M-333.9%2019-$7.83M+62.2%2018-$20.73M+30.8%2017-$29.96M-5.0%2016-$28.53M-33.4%2015-$21.38M-539.6%2014-$3.34M+57.8%2013-$7.91M+0.7%2012-$7.97M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share